Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Sven Mathias"'
Autor:
Joschka Bauer, Sven Mathias, Sebastian Kube, Kerstin Otte, Patrick Garidel, Martin Gamer, Michaela Blech, Simon Fischer, Anne R Karow-Zwick
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
The discovery of therapeutic monoclonal antibodies (mAbs) primarily focuses on their biological activity favoring the selection of highly potent drug candidates. These candidates, however, may have physical or chemical attributes that lead to unfavor
Externí odkaz:
https://doaj.org/article/4b709eb7b77347208fd2e1baab40e518
Autor:
Nikolas Zeh, Helga Schneider, Sven Mathias, Nadja Raab, Michael Kleemann, Sabine Schmidt-Hertel, Benjamin Weis, Silke Wissing, Nikola Strempel, René Handrick, Kerstin Otte
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221679 (2019)
Exosomes represent a promising delivery tool for nucleic acid-based pharmaceuticals. They are highly suitable for transporting therapeutic miRNAs to tumor cells, due to their natural membrane components. Further, exosomes are capable of effectively p
Externí odkaz:
https://doaj.org/article/dfa96773dacc49e182f77410d1b73f91
Autor:
Martin Gamer, Karlheinz Holzmann, René Handrick, Simon Fischer, Patrick Schlossbauer, Benjamin Lindner, Anna Stadermann, Nadja Raab, Kerstin Otte, Sven Mathias, Nikolas Zeh
Publikováno v:
New Biotechnology. 66:79-88
Chinese Hamster Ovary (CHO) cells are the most frequently used biopharmaceutical production hosts, although industry is presently suffering from their variable recombinant product quality, insufficient long-term stability and low productivity. Here,
Autor:
Simon Fischer, Sven Mathias, Anna Stadermann, Shumin Yang, Valerie Schmieder, Nikolas Zeh, Nicoletta Schmidt, Patrick Richter, Sara Wright, Eike Zimmermann, Yan Ley, Julia Meer, Thomas Hartsch, Christian Bernloehr, Kerstin Otte, Harald Bradl, Martin Gamer, Patrick Schulz
Publikováno v:
Biotechnology and bioengineering. 119(3)
Chinese hamster ovary (CHO) cells are known not to express appreciable levels of the sialic acid residue N-glycolylneuraminic acid (NGNA) on monoclonal antibodies. However, we actually have identified a recombinant CHO cell line expressing an IgG wit
Autor:
Theresa Buck, Jens Pfannstiel, Nikolas Zeh, Yu-Wei Shieh, Kerstin Otte, Helga Schneider, Nadja Raab, Sven Mathias, Florian Klingler
Publikováno v:
Biotechnology and bioengineeringREFERENCES. 118(8)
Chinese hamster ovary (CHO) suspension cells are the main production hosts for biopharmaceuticals. For the improvement of production processes, it is essential to understand the interaction between CHO cells and their microenvironment. While the cell
Autor:
Anne R. Karow-Zwick, Kerstin Otte, Sven Mathias, Sebastian Kube, Joschka Bauer, Martin Gamer, Patrick Garidel, Michaela Blech, Simon Fischer
Publikováno v:
mAbs
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The discovery of therapeutic monoclonal antibodies (mAbs) primarily focuses on their biological activity favoring the selection of highly potent drug candidates. These candidates, however, may have physical or chemical attributes that lead to unfavor
Autor:
Kerstin Otte, Nikolas Zeh, Nikola Strempel, Sven Mathias, René Handrick, Nadja Raab, Sabine Schmidt-Hertel, Silke Wissing, Helga Schneider, Michael Kleemann, Benjamin Weis
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 8, p e0221679 (2019)
PLoS ONE, Vol 14, Iss 8, p e0221679 (2019)
Exosomes represent a promising delivery tool for nucleic acid-based pharmaceuticals. They are highly suitable for transporting therapeutic miRNAs to tumor cells, due to their natural membrane components. Further, exosomes are capable of effectively p
Autor:
Ingo Gorr, Patrick Schulz, Simon Fischer, Martin Gamer, René Handrick, Nikolas Zeh, Anna Wippermann, Nadja Raab, Kerstin Otte, Sven Mathias
Publikováno v:
Biotechnology and bioengineeringREFERENCES. 117(1)
Although most therapeutic monoclonal antibodies (mAbs) can routinely be produced in the multigram per litre range, some mAb candidates turn out to be difficult-to-express (DTE). In addition, the class of more complex biological formats is permanently
Autor:
Kerstin Alt, René Handrick, Vaibhav Jadhav, Kerstin Otte, Nicole Borth, Simon Fischer, Nadja Raab, Sven Mathias, Valerie Schmieder
Publikováno v:
Biotechnology journal. 14(5)
MicroRNAs (miRNAs) are noncoding RNAs that serve as versatile molecular engineering tools to improve production cells by overexpression or knockdown of miRNAs showing beneficial or adverse effects on cell-culture performance. The genomic knockout (KO
Autor:
Michael Kleemann, Theresa Buck, René Handrick, Verena V. Emmerling, Matthias Hackl, Simon Fischer, Johannes Grillari, Simone Schaz, Armaz Aschrafi, Kerstin Otte, Sven Mathias
Publikováno v:
Journal of Biotechnology. 212:32-43
Functional genomics represent a valuable approach to improve culture performance of Chinese hamster ovary (CHO) cell lines for biopharmaceutical manufacturing. Recent advances in applied microRNA (miRNAs) research suggest that these small non-coding